Dynavax(DVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DVAX Dynavax

Trading 11-14 11:32:15 EST

13.54

+0.02

+0.11%

High13.71	Low13.49	Vol419.07K
Open13.58	D1 Closing13.52	Amplitude1.59%
Mkt Cap1.78B	Tradable Cap1.53B	Total Shares131.45M
T/O5.68M	T/O Rate0.37%	Tradable Shares113.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"DVAX","market":"US","secType":"STK","nameCN":"Dynavax","latestPrice":13.535,"timestamp":1731601932645,"preClose":13.52,"halted":0,"volume":419072,"delay":0,"floatShares":113200018,"shares":131454561,"eps":0.151121,"marketStatus":"Trading","change":0.015,"latestTime":"11-14 11:32:15 EST","open":13.58,"high":13.705,"low":13.49,"amount":5683902.87104,"amplitude":0.015902,"askPrice":13.54,"askSize":334,"bidPrice":13.53,"bidSize":800,"shortable":3,"etf":0,"ttmEps":0.151121,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1731618000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1077166800000,"exchange":"NASDAQ","adjPreClose":13.52,"preHourTrading":{"tag":"盘前","latestPrice":13.56,"preClose":13.52,"latestTime":"09:29 EST","volume":462,"amount":6249.080376,"timestamp":1731594599999},"postHourTrading":{"tag":"盘后","latestPrice":13.52,"preClose":13.52,"latestTime":"19:56 EST","volume":41303,"amount":558445.25,"timestamp":1731545762629},"volumeRatio":0.33834,"impliedVol":0.2298,"impliedVolPercentile":0.2421},"requestUrl":"/m/hq/s/DVAX","defaultTab":"news","newsList":[{"id":"2482856680","title":"BRIEF-Dynavax Technologies Corp Entered $100 Million Accelerated Share Repurchase Agreement With Goldman Sachs & Co. LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2482856680","media":"Reuters","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482856680?lang=en_us&edition=fundamental","pubTime":"2024-11-12 22:38","pubTimestamp":1731422312,"startTime":"0","endTime":"0","summary":"Nov 12 (Reuters) - Dynavax Technologies Corp   :   * DYNAVAX TECHNOLOGIES CORP: ENTERED $100 MILLION ACCELERATED SHARE REPURCHASE AGREEMENT WITH GOLDMAN SACHS & CO. LLCSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0004086264.USD","LU2237438978.USD","IE0004091025.USD","IE00BSNM7G36.USD","DVAX","LU2237443465.HKD","LU2237443382.USD","IE0034235188.USD","LU1791807156.HKD","LU1668664300.SGD","LU2237443549.SGD","BK4516","BK4588","BK4585","BK4533","BK4550","IE00BFXG1179.USD","IE00B19Z3581.USD","BK4139","IE0002270589.USD","LU2237443622.USD","LU0106831901.USD","BK4504","IE00B19Z3B42.SGD","BK4127","BK4552","LU2237443978.SGD","LU2237443895.HKD"],"gpt_icon":0},{"id":"2482083789","title":"Dynavax Technologies Corp: Entered $100 Mln Accelerated Share Repurchase Agreement With Goldman Sachs & Co. Llc","url":"https://stock-news.laohu8.com/highlight/detail?id=2482083789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482083789?lang=en_us&edition=fundamental","pubTime":"2024-11-12 22:36","pubTimestamp":1731422202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nFWN3MJ0UA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DVAX","BK4139"],"gpt_icon":0},{"id":"2482755631","title":"BUZZ-Dynavax rallies after $100 mln accelerated stock buyback with Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2482755631","media":"reuters","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482755631?lang=en_us&edition=fundamental","pubTime":"2024-11-12 01:56","pubTimestamp":1731347819,"startTime":"0","endTime":"0","summary":"lance.tupper@tr.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL6N3MI0LA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU1791807156.HKD","IE0004086264.USD","LU0106831901.USD","BK4139","IE0034235188.USD","IE0002270589.USD","DVAX","BK4588","LU2237443382.USD","LU2237443549.SGD","LU2237443978.SGD","BK4550","BK4585","LU2237443465.HKD","IE0004091025.USD","BK4533","IE00B19Z3581.USD","LU2237443622.USD","IE00B19Z3B42.SGD","BK4127","LU1668664300.SGD","LU2237438978.USD","BK4552","LU2237443895.HKD","IE00BSNM7G36.USD","BK4516","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2482759213","title":"Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2482759213","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482759213?lang=en_us&edition=fundamental","pubTime":"2024-11-12 01:00","pubTimestamp":1731344410,"startTime":"0","endTime":"0","summary":"Investors might want to bet on Dynavax Technologies , as it has been recently upgraded to a Zacks Rank #2 . This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.As such, the Zacks rating upgrade for Dynavax Technologies is essentially a positive comment on its earnings outlook that could have a favorable ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZVGBNd2_.kAicju5mLde7g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZVGBNd2_.kAicju5mLde7g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dynavax-technologies-dvax-upgraded-buy-170010633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DVAX"],"gpt_icon":0},{"id":"2482737547","title":"Wall Street Analysts Predict an 88.32% Upside in Dynavax Technologies (DVAX): Here's  What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2482737547","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482737547?lang=en_us&edition=fundamental","pubTime":"2024-11-11 22:55","pubTimestamp":1731336910,"startTime":"0","endTime":"0","summary":"Dynavax Technologies  closed the last trading session at $13.01, gaining 24.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $24.50 indicates an 88.3% upside potential.However, an impressive consensus price target is not the only factor that indicates a potential upside in DVAX. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wbCMwMtKIoXj_iQA0ego4g--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wbCMwMtKIoXj_iQA0ego4g--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wall-street-analysts-predict-88-145510222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DVAX","BK4139"],"gpt_icon":0},{"id":"1131570305","title":"Stock Track | Dynavax Soars Over 5% on $100M Accelerated Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1131570305","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131570305?lang=en_us&edition=fundamental","pubTime":"2024-11-11 22:32","pubTimestamp":1731335567,"startTime":"0","endTime":"0","summary":"Shares of Dynavax Technologies Corp.  surged over 5% on Friday after the biopharmaceutical company announced it has entered into a $100 million accelerated share repurchase  agreement with Goldman Sachs.The ASR is part of Dynavax's recently approved $200 million share buyback program. Under the terms of the agreement, Dynavax will receive an initial delivery of approximately 6.1 million shares, representing around 80% of the total $100 million repurchase amount. The final number of shares to be ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Dynavax Soars Over 5% on $100M Accelerated Share Buyback Plan","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DVAX"],"gpt_icon":0},{"id":"2482845177","title":"Dynavax Technologies to Repurchase $100 Million From Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2482845177","media":"MT Newswires Live","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482845177?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:43","pubTimestamp":1731332626,"startTime":"0","endTime":"0","summary":"Dynavax Technologies  said Monday it signed a deal with Goldman Sachs  to repurchase $100 million of shares under an accelerated share repurchase transaction, or ASR.The transaction is part of Dynavax's $200 million share repurchase program launched this month, the company said. After the ASR is completed, Dynavax will have $100 million remaining under the buyback.Dynavax said it will pay $100 million to Goldman Sachs to initially receive approximately 6.1 million shares. The final number to be repurchased will be based on volume-weighted average prices of the company's stock during the term of the ASR, the company said.The final settlement of the ASR is expected to be completed in Q1 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4552","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","DVAX","LU2237443465.HKD","LU2237443549.SGD","LU2237443622.USD","LU1668664300.SGD","IE0002270589.USD","LU2237443382.USD","BK4533","LU2237438978.USD","IE0004091025.USD","BK4516","LU1791807156.HKD","BK4585","LU2237443978.SGD","IE00B19Z3581.USD","LU2237443895.HKD","BK4504","LU0106831901.USD","BK4139","BK4588","IE0004086264.USD","BK4127","BK4550","IE00BFXG1179.USD","IE0034235188.USD"],"gpt_icon":0},{"id":"2482726781","title":"Dynavax Technologies Sets $100 Million Accelerated Stock Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2482726781","media":"Dow Jones","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482726781?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:35","pubTimestamp":1731332100,"startTime":"0","endTime":"0","summary":"Dynavax Technologies said it inked a $280 million accelerated share-repurchase agreement with Goldman Sachs.The biopharmaceutical Dynavax on Monday said it expects an initial delivery of about 6.1 million shares, representing roughly 80% of the deal, with final settlement in the first quarter.The Emeryville, Calif., company, which has nearly 131.5 million shares outstanding and has a market capitalization topping $1.7 billion, said it is making the accelerated buyback as part of the $200 million buyback program it announced last week, adding that it will have $100 million remaining under the program.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","LU2237443465.HKD","LU2237443895.HKD","LU2237443382.USD","LU2237443978.SGD","BK4585","LU2237443549.SGD","LU1791807156.HKD","LU2237438978.USD","IE0004086264.USD","BK4139","IE00BSNM7G36.USD","LU0106831901.USD","IE00B19Z3B42.SGD","BK4588","BK4533","IE0002270589.USD","BK4127","BK4504","IE0004091025.USD","BK4552","LU2237443622.USD","IE00B19Z3581.USD","IE00BFXG1179.USD","BK4550","LU1668664300.SGD","DVAX","BK4516"],"gpt_icon":0},{"id":"2482362784","title":"Dynavax enters $100M accelerated share repurchase agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2482362784","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482362784?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:14","pubTimestamp":1731330866,"startTime":"0","endTime":"0","summary":"Dynavax Technologies (NASDAQ:DVAX) has signed an accelerated share repurchase (ASR) agreement with Goldman Sachs to buy back $100M of its common stock. \nThe transaction is part of the $200M share repurchase program authorized by the board this month. Upon completion of this","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4274128-dynavax-enters-100m-accelerated-share-repurchase-agreement","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["IE0002270589.USD","ASR.AU","DVAX","NQmain","BK4504","BK4588","IE00BFXG1179.USD","SQQQ","BK4533","BK4552","MNQmain","IE0004091025.USD","LU2125910500.SGD","LU2237443622.USD","BK7104","LU2045819591.USD","QID","PSQ","BK4550","BK4139","BK4585","QLD","LU2237443382.USD","LU1791807156.HKD","LU0210535034.USD","LU2237438978.USD","IE00B19Z3B42.SGD","LU2237443895.HKD","BK4516","IE00B19Z3581.USD","LU2237443465.HKD","LU2237443978.SGD","LU1668664300.SGD","LU0106831901.USD","LU2237443549.SGD","BK4174","IE00BSNM7G36.USD","IE0004086264.USD","ASR","TQQQ","IE0034235188.USD","BK4127",".IXIC"],"gpt_icon":0},{"id":"2482005786","title":"BRIEF-Dynavax Announces $100 Million Accelerated Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2482005786","media":"reuters","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482005786?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:01","pubTimestamp":1731330086,"startTime":"0","endTime":"0","summary":"BRIEF-Dynavax Announces $100 Million Accelerated Share Repurchase ProgramNov 11 (Reuters) - Dynavax Technologies Corp DVAX.O:DYNAVAX ANNOUNCES $100 MILLION ACCELERATED SHARE REPURCHASE PROGRAMSource text: ID:nPn2hDDT7aFurther company coverage: DVAX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nTUA6NW1RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVAX","BK4139"],"gpt_icon":0},{"id":"2482678612","title":"Dynavax Announces $100 Million Accelerated Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2482678612","media":"THOMSON REUTERS","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482678612?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:00","pubTimestamp":1731330012,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nTUA6NW1RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DVAX","BK4139"],"gpt_icon":0},{"id":"2482261986","title":"Dynavax Technologies Corporation Just Recorded A 9.1% EPS Beat: Here's What Analysts Are Forecasting Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2482261986","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482261986?lang=en_us&edition=fundamental","pubTime":"2024-11-10 22:01","pubTimestamp":1731247299,"startTime":"0","endTime":"0","summary":"Shareholders of Dynavax Technologies Corporation  will be pleased this week, given that the stock price is up 10% to US$13.01 following its latest third-quarter results. Results look mixed - while revenue fell marginally short of analyst estimates at US$81m, statutory earnings beat expectations 9.1%, with Dynavax Technologies reporting profits of US$0.12 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We thought readers would find it interesting to see the analysts latest  post-earnings forecasts for next year.The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increas","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dynavax-technologies-corporation-just-recorded-140139656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DVAX"],"gpt_icon":0},{"id":"2482288634","title":"Dynavax Technologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2482288634","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482288634?lang=en_us&edition=fundamental","pubTime":"2024-11-09 20:48","pubTimestamp":1731156493,"startTime":"0","endTime":"0","summary":"Profit margin: 22% . The increase in margin was driven by higher revenue.NasdaqGS:DVAX Earnings and Revenue History November 9th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 4.2%. Earnings per share  exceeded analyst estimates by 9.1%.Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are up 10% from a week ago.Don't forget that there may still be risks. For instance, we've identified   1 warning sign for Dynavax Technologies  that you should be aware of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dynavax-technologies-third-quarter-2024-124813634.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DVAX"],"gpt_icon":0},{"id":"2482139824","title":"Dynavax Technologies’ $200M Share Buyback: Potential Risks and Financial Implications","url":"https://stock-news.laohu8.com/highlight/detail?id=2482139824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482139824?lang=en_us&edition=fundamental","pubTime":"2024-11-09 14:00","pubTimestamp":1731132016,"startTime":"0","endTime":"0","summary":"Dynavax Technologies (DVAX) has disclosed a new risk, in the Share Price & Shareholder Rights category. Dynavax Technologies faces a potential risk...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dynavax-technologies-200m-share-buyback-potential-risks-and-financial-implications?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dynavax-technologies-200m-share-buyback-potential-risks-and-financial-implications?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DVAX"],"gpt_icon":0},{"id":"2482438088","title":"Dynavax rises 11% on Q3 bottom line beat, 2024 positive net income expectation","url":"https://stock-news.laohu8.com/highlight/detail?id=2482438088","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482438088?lang=en_us&edition=fundamental","pubTime":"2024-11-09 01:04","pubTimestamp":1731085466,"startTime":"0","endTime":"0","summary":"jurgenfr Dynavax Technologies (NASDAQ:DVAX) is up ~11% in Friday trading after reporting Q3 financial results after the Nov. 7 closing bell that beat on the bottom line and saying it expects positive net income for 2024. The company narrowed its HEPLISAV-B","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/185015106/image_185015106.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/185015106/image_185015106.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4267258-dynavax-rises-11-percent-on-q3-bottom-line-beat-2024-positive-net-income-expectation","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["DVAX","BK4139"],"gpt_icon":0},{"id":"2482293482","title":"Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2482293482","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482293482?lang=en_us&edition=fundamental","pubTime":"2024-11-09 01:02","pubTimestamp":1731085323,"startTime":"0","endTime":"0","summary":"Net Product Sales: $79 million for Hep B in Q3 2024.Market Share: Hep B achieved 44% total U.S. market share in Q3 2024, up from 41% in Q3 2023.Gross Margin: Improved to 84% in Q3 2024 and 82% for the first nine months of 2024.Cash and Equivalents: Approximately $764 million at the end of Q3 2024.Full Year Revenue Guidance: Narrowed to $265 to $270 million for Hep B net product revenue in 2024.SG&A Expenses: $43 million for Q3 2024, up from $38 million in Q3 2023.Share Repurchase Plan: $200 million authorized by the board.GuruFocus has detected 3 Warning Sign with DVAX.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Dynavax Technologies Corp  reported record net product sales of $79 million for Hep B in the third quarter.The company achieved a 44% market share in the US for Hep B, up from 41% in the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dynavax-technologies-corp-dvax-q3-170203117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DVAX"],"gpt_icon":0},{"id":"1130916740","title":"Stock Track | Dynavax Shares Soar on Strong Q3 Results, Share Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=1130916740","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130916740?lang=en_us&edition=fundamental","pubTime":"2024-11-08 22:38","pubTimestamp":1731076696,"startTime":"0","endTime":"0","summary":"Shares of Dynavax Technologies  surged over 5% on Wednesday, fueled by the company's stellar third-quarter financial results and a newly announced $200 million share repurchase program.Dynavax reported record quarterly net product sales of $79 million for its hepatitis B vaccine HEPLISAV-B, driven by increased market share across key segments like retail pharmacy and integrated delivery networks . The company's gross margin also improved to an impressive 84% in Q3, reflecting operational efficie","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DVAX"],"gpt_icon":0},{"id":"2481854106","title":"Sector Update: Health Care Stocks Edge Higher Premarket Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2481854106","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481854106?lang=en_us&edition=fundamental","pubTime":"2024-11-08 22:07","pubTimestamp":1731074865,"startTime":"0","endTime":"0","summary":"Health care stocks were edging higher premarket Friday, with the iShares Biotechnology ETF  up 0.2% and The Health Care Select Sector SPDR Fund  0.1% higher.AlloVir  shares were down more than 32% after the company said it agreed to merge with Kalaris Therapeutics in an all-stock deal.Dynavax Technologies  stock was over 2% higher after the company said it has authorized the repurchase of up to $200 million in stock.Baxter International  shares were down 0.8% after the company reported lower Q3 adjusted earnings and cut its 2024 guidance.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BAX","IBB","LU0006061336.USD","LU0310799852.SGD","LU1303367103.USD","BK4139","BK4588","BK4581","LU1267930490.SGD","DVAX","LU0211327993.USD","LU2098885051.SGD","BK4504","ALVR","BK4082","BK4585","XLV","LU0211328371.USD"],"gpt_icon":0},{"id":"2481789121","title":"Dynavax Price Target Maintained With a $29.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2481789121","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481789121?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:29","pubTimestamp":1731065340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DVAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 08, 2024 06:29 ET (11:29 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVAX"],"gpt_icon":0},{"id":"2481312075","title":"Dynavax Technologies Authorizes $200 Million Stock Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2481312075","media":"MT Newswires Live","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481312075?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:22","pubTimestamp":1731064933,"startTime":"0","endTime":"0","summary":"Dynavax Technologies  said late Thursday that it has authorized the repurchase of up to $200 million in stock.The repurchase program lacks an expiration date. The pharmaceutical company said it expects that purchases to be completed within a year.Price: 11.61, Change: -0.17, Percent Change: -1.44","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DVAX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dynavax.com","stockEarnings":[{"period":"1week","weight":0.1001},{"period":"1month","weight":0.2925},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.2169},{"period":"1year","weight":-0.0203},{"period":"ytd","weight":-0.0329}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.022},{"period":"3month","weight":0.0798},{"period":"6month","weight":0.1279},{"period":"1year","weight":0.3308},{"period":"ytd","weight":0.2564}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.001226},{"month":2,"riseRate":0.4,"avgChangeRate":-0.032132},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.004913},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.001867},{"month":5,"riseRate":0.52381,"avgChangeRate":0.03134},{"month":6,"riseRate":0.47619,"avgChangeRate":0.023947},{"month":7,"riseRate":0.52381,"avgChangeRate":0.055365},{"month":8,"riseRate":0.47619,"avgChangeRate":0.046448},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.028136},{"month":10,"riseRate":0.47619,"avgChangeRate":-0.004916},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043865},{"month":12,"riseRate":0.55,"avgChangeRate":0.141881}],"exchange":"NASDAQ","name":"Dynavax","nameEN":"Dynavax"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Dynavax(DVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Dynavax(DVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Dynavax,DVAX,Dynavax股票,Dynavax股票老虎,Dynavax股票老虎国际,Dynavax行情,Dynavax股票行情,Dynavax股价,Dynavax股市,Dynavax股票价格,Dynavax股票交易,Dynavax股票购买,Dynavax股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Dynavax(DVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Dynavax(DVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction